Covance Central Laboratory Services SA Revenue and Competitors

Grosvenor Place, AU

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Covance Central Laboratory Services SA's estimated annual revenue is currently $16.6M per year.(i)
  • Covance Central Laboratory Services SA's estimated revenue per employee is $155,000

Employee Data

  • Covance Central Laboratory Services SA has 107 Employees.(i)
  • Covance Central Laboratory Services SA grew their employee count by -15% last year.

Covance Central Laboratory Services SA's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$116.6M752-23%N/AN/A
#2
$42.3M273N/AN/AN/A
#3
$15.3M994%N/AN/A
#4
$17.8M11513%N/AN/A
#5
$19.7M12717%N/AN/A
#6
$26.8M17319%N/AN/A
#7
$16.6M107-15%N/AN/A
#8
$12.7M82-29%N/AN/A
#9
$9.7M102-15%$412.3MN/A
#10
$25.9M1677%N/AN/A
Add Company

What Is Covance Central Laboratory Services SA?

Covance is a drug development service company that, through unique perspective and precision delivery, has helped bring one-third of prescription drugs on the market today from potential to reality.

keywords:N/A

N/A

Total Funding

107

Number of Employees

$16.6M

Revenue (est)

-15%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Covance Central Laboratory Services SA News

2022-04-17 - Contract Research Organization (CRO) Services Market To ...

KCR S.A.; PSI; Parexel International Corporation. Covance Inc. Segmentation. The report covers in-depth various types of segmentation ranging...

2022-04-17 - Contract Research Organization (CROs) Services Market Size ...

Laboratory services is further sub segmented into bioanalytical ... in the functional services like the central laboratories, imaging,...

2022-04-17 - Drug Discovery Outsourcing Market Analysis by Industry ...

... Pharmaceutical Services Ltd., Selvita, Dalton Pharma Services, ... Covance Inc., Nanosyn, Bioduro, Sygnature Discovery, Laboratory...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$76.4M2860%N/A
#2
$123.6M402N/AN/A
#3
$77.8M479N/AN/A
#4
$75M558-1%N/A
#5
$75M6047%N/A